Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Phase I Dose-Escalation Study of Cpi-613, in Combination with Bendamustine, in Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Zanetta S. Lamar, MD, Scott Isom, MS, Rakhee Vaidya, MD, Anne W Beaven, MD, Zachariah A. McIver, DO

Blood (2016) 128 (22): 4163.

https://doi.org/10.1182/blood.V128.22.4163.4163

Published: 2016

Journal Articles

P-Glycoprotein Modulation Facilitates the Selective Inhibition of Oxidative Phosphorylation in Alloreactive T Cells to Prevent Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant

Zachariah A. McIver, DO, James P Phipps, MS, Jason M Grayson, PhD, Jacqueline E Hill, Gregory A Schamerhorn, PhD, Tymish Y Ohulchanskyy, PhD, Michelle K Linder, Kellie S Davies, Roy S Weiner, MD, Michael R Detty, PhD

Blood (2015) 126 (23): 1879.

https://doi.org/10.1182/blood.V126.23.1879.1879

Published: 2015

Journal Articles

Initial Genomic Analysis of a Pure Erythroid Leukemia Developing in Association with Hydroyurea Treatment for Sickle Cell Anemia

Zhengyuan Wang, Ph.D., Deepika S. Darbari, M.D., J. Joseph Melenhorst, Ph.D., Zachariah A. McIver, DO, Irina Maric, MD, Lena Diaw, Ph.D., Young Song, Ph.D., Peter Johansson, Ph.D., Jianbin He, Ph.D., Zhou Weiyin, Ph.D., Kevin B. Jacobs, M.S., Jun Wei, Ph.D., A. John Barrett, MD, Javed Khan, M.D., James G. Taylor, M.D.

Blood (2012) 120 (21): 3254.

https://doi.org/10.1182/blood.V120.21.3254.3254

Published: 2012

Journal Articles

Second Stem Cell Transplantation (SCT) for Relapsed Leukemia Provides Only Modest Prolongation of Survival

Zachariah A. McIver, DO, Thomas Hughes, Pharm D, Sawa Ito, MD, Minoo Battiwalla, MD, MS, Eleftheria K. Koklanaris, BSN, Janice Haggerty, RN, Nancy F. Hensel, BS, A. John Barrett, MD

Blood (2011) 118 (21): 2001.

https://doi.org/10.1182/blood.V118.21.2001.2001

Published: 2011

Journal Articles

Low Thymic Natural Regulatory T Cell Output in the Donor Is Associated with An Increased Incidence of Extensive Chronic GvHD After T Cell Depleted Matched Sibling Stem Cell Transplantation (SCT)

Zachariah A. McIver, DO, J. Joseph Melenhorst, PhD, Haiyun Zheng, Colin O. Wu, PhD, Andrew Grim, BS, Sawa Ito, MD, Irene Cho, BS, Nancy F. Hensel, BS, A. John Barrett, MD, FRCP, FRCPath

Blood (2011) 118 (21): 328.

https://doi.org/10.1182/blood.V118.21.328.328

Published: 2011

Journal Articles

4-Log Ex-Vivo T-Lymphocyte Depleted Myeloablative HLA-Matched Sibling Transplants; a Platform for Adoptive Immunotherapy

Minoo Battiwalla, MD, MS, Zachariah A. McIver, DO, Janice Haggerty, Eleftheria K. Koklanaris, BS, Kamna Chawla, MD, MS, Jeanine Superata, Richard Childs, MD, Roger Kurlander, MD, David Stroncek, MD, Hanh Khuu, Deborah Citrin, Marianna Sabatino, MD, Susan Leitman, MD, A. John Barrett, MD

Blood (2010) 116 (21): 2091.

https://doi.org/10.1182/blood.V116.21.2091.2091

Published: 2010

Journal Articles

Selective Depletion of T Cell Alloresponses Using a Photodepletion Strategy Preferentially Targets CD4+ T Cells.

Zachariah A. McIver, DO, Andrew Grim, BS, Nicolas Naguib, BS, Hahn Khuu, Minoo Battiwalla, MD, MS, David Stroncek, MD, A. John Barrett, MD

Blood (2010) 116 (21): 1467.

https://doi.org/10.1182/blood.V116.21.1467.1467

Published: 2010

Journal Articles

Selectively T Cell Depleted Allografts From HLA-Matched Sibling Donors Followed by Low-Dose Post Transplant Immunosuppression to Limit Disease Relapse In Patients with Hematological Malignancies

Zachariah A. McIver, DO, Stephan Mielke, MD, Aarthi Shenoy, MD, Vicki Fellows, David Stroncek, MD, Susan Leitman, MD, Richard Childs, MD, Minoo Battiwalla, MD, MS, Eleftheria K. Koklanaris, BS, Janice Haggerty, RN, Bipin N. Savani, MD, Katy Rezvani, A. John Barrett, MD

Blood (2010) 116 (21): 4705.

https://doi.org/10.1182/blood.V116.21.4705.4705

Published: 2010

Journal Articles

Allografts Selectively Photodepleted of GvHD Causing T Cells and Followed by Low-Level Immunosuppression: A Novel Method to Improve Disease Control After HLA-Matched Sibling Transplantations.

Stephan Mielke, MD, Aarthi Shenoy, MD, Katayoun Rezvani, MD, PhD, Agnes S. M. Yong, MD, PhD, Zachariah A. McIver, DO, Vicki S. Fellowes, Bipin N. Savani, MD, Roger Kurlander, MD, Hanh Khuu, MD, Carol Boss, A.John Barrett, MD, FRCP

Blood (2009) 114 (22): 515.

https://doi.org/10.1182/blood.V114.22.515.515

Published: 2009

Journal Articles

Low Absolute CD4 Central Memory Count On Day 30 Is Associated with An Increased Incidence of Chronic Graft-Versus-Host Disease.

Zachariah A. McIver, DO, Andrew Grim, BS, Nicolas Naguib, BS, A. John Barrett, MD

Blood (2009) 114 (22): 516.

https://doi.org/10.1182/blood.V114.22.516.516

Published: 2009

Journal Articles

Rituximab Administration within 6 Months of Allogeneic SCT Carries Risk of Prolonged and Life Threatening Cytopenias.

Zachariah A. McIver, DO, Nicole Stephens, BS, Nicolas Naguib, BS, Andrew Grim, BS, A. John Barrett, MD

Blood (2009) 114 (22): 793.

https://doi.org/10.1182/blood.V114.22.793.793

Published: 2009

Journal Articles

Double Negative T Cells Influence TCR VB Variablity to Induce Allotolerance.

Zachariah A. McIver, DO, Marcin Wlodarski, MD, Jennifer Powers, BS, Christine O’Keefe, PhD, Tao Jin, MS, Ronald Sobecks, MD, Brian J. Bolwell, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2006) 108 (11): 759.

https://doi.org/10.1182/blood.V108.11.759.759

Published: 2006

Journal Articles

Survival and Predictors of Outcome in Acute Leukemia Patients Admitted to the Intensive Care Unit.

Snehal G. Thakkar, MD, Zachariah A. McIver, DO, Sanjay R. Mohan, MD, Giridharan Ramsingh, MD, Anjali S. Advani, MD, Ronald Sobecks, MD, Lisa Rybicki, Alejandro Arroliga, MD, Matthew Kalaycio, MD, Mikkael A. Sekeres, MD

Blood (2005) 106 (11): 2778.

https://doi.org/10.1182/blood.V106.11.2778.2778

Published: 2005

NARROW

Phase I Dose-Escalation Study of Cpi-613, in Combination with Bendamustine, in Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

P-Glycoprotein Modulation Facilitates the Selective Inhibition of Oxidative Phosphorylation in Alloreactive T Cells to Prevent Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant

Initial Genomic Analysis of a Pure Erythroid Leukemia Developing in Association with Hydroyurea Treatment for Sickle Cell Anemia

Second Stem Cell Transplantation (SCT) for Relapsed Leukemia Provides Only Modest Prolongation of Survival

Low Thymic Natural Regulatory T Cell Output in the Donor Is Associated with An Increased Incidence of Extensive Chronic GvHD After T Cell Depleted Matched Sibling Stem Cell Transplantation (SCT)

4-Log Ex-Vivo T-Lymphocyte Depleted Myeloablative HLA-Matched Sibling Transplants; a Platform for Adoptive Immunotherapy

Selective Depletion of T Cell Alloresponses Using a Photodepletion Strategy Preferentially Targets CD4+ T Cells.

Selectively T Cell Depleted Allografts From HLA-Matched Sibling Donors Followed by Low-Dose Post Transplant Immunosuppression to Limit Disease Relapse In Patients with Hematological Malignancies

Allografts Selectively Photodepleted of GvHD Causing T Cells and Followed by Low-Level Immunosuppression: A Novel Method to Improve Disease Control After HLA-Matched Sibling Transplantations.

Low Absolute CD4 Central Memory Count On Day 30 Is Associated with An Increased Incidence of Chronic Graft-Versus-Host Disease.

Rituximab Administration within 6 Months of Allogeneic SCT Carries Risk of Prolonged and Life Threatening Cytopenias.

Double Negative T Cells Influence TCR VB Variablity to Induce Allotolerance.

Survival and Predictors of Outcome in Acute Leukemia Patients Admitted to the Intensive Care Unit.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only